Fairfield, Bush & Co’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-90
Closed -$2.84K – 164
2023
Q4
$2.84K Buy
+90
New +$2.44K ﹤0.01% 373
2023
Q3
– Sell
-90
Closed -$3.32K – 162
2023
Q2
$3.32K Buy
+90
New +$2.75K ﹤0.01% 391
2022
Q3
– Sell
-90
Closed -$3K – 162
2022
Q2
$3K Buy
+90
New +$3.31K ﹤0.01% 374

Other funds holding CC

Fairfield, Bush & Co's CC Position: Q1 2024 in Review

Fairfield, Bush & Co sold out of Chemours (CC) in Q1 2024, closing a stake of 90 shares — an estimated $2.84K sold.

Fairfield, Bush & Co first reported a position in CC in Q2 2022 and held it in 3 quarters. The position peaked at $3.32K in Q2 2023. 444 funds tracked by Wall St. Rank hold CC as of Q1 2024.

  • Fairfield, Bush & Co reported no remaining Chemours position as of Q1 2024 after selling out during the quarter.
  • Fairfield, Bush & Co sold 90 Chemours shares in Q1 2024, an estimated $2.84K.
  • Fairfield, Bush & Co first reported a position in Chemours in Q2 2022 and held it in 3 quarters.
  • Fairfield, Bush & Co's Chemours position peaked at $3.32K in Q2 2023.
  • 444 funds tracked by Wall St. Rank held Chemours as of Q1 2024.

Based on Fairfield, Bush & Co's 13F filing for Q1 2024, filed 15 May 2024.